INTRODUCTION
In mammals, the endogenous circadian pacemaker is located in the suprachiasmatic nuclei (SCN) of the hypothalamus. The SCN not only generate the rhythmic expression of behavioral and physiological processes but also synchronize these rhythms to the environmental light:dark (LD) cycle (Meijer and Rietveld, 1989; Miller et al., 1996) . The SCN receive information about the environmental LD cycle directly from the retina via the retinohypothalamic tract (Moore and Lenn, 1972; Pickard, 1982) and indirectly via the intergeniculate leaflet (IGL) and the geniculohypothalamic tract (Card and Moore, 1982 Harrington et al., 1985 Harrington et al., , 1987 , the gene that has been studied most extensively is c-fos (for a review, see Komhauser et al.,1993) . Light pulses provided at specific times during the circadian cycle stimulate the transcription of c-fos and its translation to its protein product, Fos, within the SCN (Kornhauser et al., 1990; Rea, 1989; Rusak et al., 1990) . Fos forms heterodimers with the protein products of the Jun family, and these heterodimers are capable of binding to the AP-1 response element to further alter gene transcription (Vogt and Bos, 1990 In nocturnal rodents (i.e., rats and hamsters) housed under constant dark conditions, light pulses given during the late subjective day and subjective night produce phase shifts in activity rhythms and result in an increase in Fos expression, primarily within the ventrolateral portion of the SCN (Aronin et al., 1990; Kornhauser et al., 1990; Rea, 1989 Rea, , 1992 Rusak et al., 1990; Schwartz et al., 1994) . Light pulses given during the subjective day (circadian times [CTs] (Kornhauser et al.,1990) . Second (Ebling et al., 1991) . Treatment with excitatory amino acid antagonists blocks the effects of light on both activity rhythms and Fos expression (Abe et al., 1992; Colwell et al., 1991; Rea et al., 1993) . Finally, administering antisense oligonucleotides directed against c fos and junB to the SCN blocks light-induced phase shifts in activity rhythms (Wollnik et al., 1995 (Hickey and Spear, 1976; Pickard, 1985) . Neurons within the IGL containing neuropeptide Y Moore, 1982, 1988; Harrington et al., 1985 Harrington et al., , 1987 , gamma-amino butyric acid (Moore and Card, 1994; Moore and Speh, 1993) , and in some species met-enkephalin (Morin et al., 1992) send projections to the ventrolateral portion of the SCN and appear to be involved in mediating photic- (Dark and Asdourian, 1975; Rusak, 1986, 1988) and nonphotic-induced phase shifts (for a review, see Mrosovsky, 1995) . Lesioning the IGL alters light-induced phase shifts (Harrington and Rusak, 1986; Johnson et al., 1989; Pickard et al.,1987) and entrainment to the environmental LD cycle (Harrington and Rusak, 1986; Johnson et al., 1989; Pickard, 1989 Lee, 1995b, 1996; Labyak and Lee, 1995) from South America with a well-characterized phase response curve to light (Lee and Labyak, 1997 Because retinal projections to the IGL also have been described in degus (Goel and Lee, 1995a ; N. Goel (Hickey and Spear, 1976; Pickard, 1985) and degus (Goel and Lee, 1995a; Photomicrographs of Fos labeling in the IGL of rats and degus are presented in Fig. 6 . In both degus and rats, light exposure resulted in an increase in the number of Fos' cells in the IGL. In degus, the two-way ANOVA found a main effect of treatment (Fig. 7) , F(l, 13) = 4.91, p < .05, with the number of Fos' cells being greater in the IGL of pulsed animals than control animals, but no effect of time and no interaction. In rats, there also was a significant effect of treatment on the number of Fos' cells in the IGL (Fig. 7) . Activation of the cAMP pathway is capable of inducing the transcription of both c-fos (Sheng and Greenberg, 1990 ) and a specific isoform of CREM named the inducible cAMP early repressor (ICER), which is a powerful inhibitor of cAMP-induced transcription Stehle et al., 1993 (Ginty et al., 1993; Golombek and Ralph, 1994) . CREB binds to the Ca2+/cAMP response element on the c-fos promoter and regulates transcription (Sheng and Greenburg, 1990 (Foulkes et al., 1996; Stehle et al., 1993) It also is possible that the decline in Fos immunostaining in response to light at CT 4 was due to an interaction between light and activity at CT 4 in degus. Because degus are diurnal, they normally see light during the active period of their cycle. Thus, it is not unreasonable to think that activity may modulate the effects of light during the subjective day. One pathway by which activity may alter the effects of light on Fos staining is through the serotonergic (5HT) projection from the raphe (Moore et al., 1978; Morin, 1994) . In hamsters, treatment with the 5HT precursor, tryptophan, reduces the size of light-induced phase shifts and in Fos immunostaining within the SCN (Glass et al., 1995) . In in vitro slice preparations from rats, basal expression of c-fos mRNA in the dorsomedial SCN is high in untreated slices at CT 6, but treatment with the 5HT agonist quipaizine results in a decrease in Fos expression at this time (Prosser et al., 1994) . Thus, it appears as if 5HT can inhibit both light-induced and basal expression of Fos in the SCN of nocturnal rodents. The 5HT projection in degus is similar to that reported for other species (Morin, 1994) ; 5HT terminals are found primarily within the ventrolateral portion of the nucleus (Goel et al., submitted) . Therefore, the pathway by which 5HT could modulate the effects of light exists in degus. In hamsters, endogenous 5HT release is higher during the dark phase of the cycle, when animals are active. In fact, the highest levels of 5HT release are highly correlated with bouts of activ-4 ity (Dudley and Glass, 1996) . Because (Earnest et al., 1990) and in in vitro slice preparations obtained from rats (Prosser et al., 1994) (Peters et al.,1994 (Aronin et al., 1990; Edelstein and Amir, 1996; Kornhauser et al., 1990; Rea, 1989 Rea, , 1992 Rusak et al., 1990; Schwartz et al., 1994 (Edelstein and Amir, 1996; Rusak et al., 1990 (Lee and Labyak, 1997 (Kornhauser et al., 1990; Wollnik et al., 1995) . However, in diurnal mammals such as degus, which are sensitive to the phase-shifting effects of light during the subjective day, the cellular and molecular pathways by which Fos is acting may be different for light pulses presented during the subjective day versus those presented during the subjective night. 
